The latest price of giritinib

In recent years, giritinib has been widely recognized globally as a targeted drug for the treatment of patients with FLT3 mutation-positive acute myeloid leukemia (AML). By inhibiting the activity of FLT3 kinase, giritinib can effectively control the progression of the disease and bring clinical benefits to patients. Multiple clinical trials have shown that giritinib can significantly extend the overall survival of patients and improve the complete response rate. In addition to its remarkable efficacy, giritinib also has a good safety profile. Currently, the selling price of giritinib has received much attention, and this article will introduce it in detail.

Currently, giritinib is on the market in China, but due to its high research and development costs and the fact that it has not yet been included in the medical insurance catalog, its price is relatively high. According to the latest data, in the domestic market, the selling price of the original drug gilitinib is approximately 25,000 yuan per box. The specific prices vary depending on factors such as regions, pharmacies, etc. Patients are advised to consult themselves.

Fortunately, however, generic versions of giritinib are now on the market. Generic drugs have obvious price advantages over original drugs. For example, the generic version of giritinib produced by Lucius in Laos sells for about 3,000 per box. This price is more affordable than the original drug, allowing more patients to afford treatment. In addition, there are versions produced by Daxiong Pharmaceutical and Laos ASEAN Pharmaceutical in Laos, which are much cheaper than the original drug. It is worth mentioning that these generic drugs have been approved by the government and are officially marketed drugs with guaranteed quality. However, despite the price advantage of generic drugs, patients still need to be cautious when purchasing. Make sure to purchase generic drugs from regular channels to avoid drug quality issues that may affect the treatment effect.